Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term statin pretreatment and endothelial dysfunction from ischemia-reperfusion injury
2009-014831-18Phase 4Active
- Sponsor
- Radboud University Medical Center
- Start
- Aug 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of rosuvastatin and atorvastatin in ischemia-reperfusion injury (IRI) (5 arms), sponsored by Radboud University Medical Center. Primary endpoint: Flow-mediated dilation change after ischemia-reperfusion. Started Aug 2009; status: active.
02
Drugs
rosuvastatinatorvastatin
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on 2009-014831-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014831-18.